Subject
Gastroenterology,Hepatology
Reference12 articles.
1. Sorafenib in advanced hepatocellular carcinoma;Llovet;N Engl J Med,2008
2. Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcino ma: a phase III randomised, double-blind, placebo-controlled trial;Cheng;Lancet Oncol,2009
3. Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): a phase 3, randomised, double-blind, placebo-controlled trial;Bruix;Lancet Oncol,2015
4. Sorafenib in combination with transarterial chemoembolisation in patients with unresectable hepatocellular carcinoma (TACE 2): a randomised placebo-controlled, double-blind, phase 3 trial;Meyer;Lancet Gastroenterol Hepatol,2017
5. Advances in targeted therapies for hepatocellular carcinoma in the genomic era;Llovet;Nat Rev Clin Oncol,2015
Cited by
18 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献